Dr Sri Srinivasan has more than 11 years of research experience in prostate cancer genetics and molecular biology. She completed her Master degrees in Microbial Gene Technology and Biotechnology in India in 2007.  In 2017, she completed her PhD in prostate cancer genetics and molecular biology at Queensland University of Technology (QUT) . Her research focuses on understanding the biological impact of prostate cancer risk associated germline variants in prostate cancer predisposition and development; and identifying novel biomarkers for accurate diagnosis and prognosis specifically for metastatic PCa which is associated with severe morbidity and disease outcomes. Dr Srinivasan received an Advanced Queensland Research Fellowship in 2017 to pursue her research as an Early Career Researcher at QUT in partnership with Queensland Health (Pathology) and the Translation Research Institute, Brisbane. In 2018, she received the John Mills Prostate Cancer Foundation of Australia’s Young Investigator Award to navigate the successful translation of novel prostate cancer diagnostics. In 2017, she was a national finalist of the  Women In Technology (WiT) Life Sciences Young Achiever Award. She has received many other awards, noteworthy is her E.K. Frey-Werle  Foundation Award in 2019, multiple travel grants and opportunities to present her research at International conferences. Dr Sri Srinivasan has also co-authored publications in high impact factor journals such as Nature Genetics, Cancer Discovery, Nature Communications and Clinical Chemistry among others.